Improving Quality of Life and Patient Adherence in Multiple Sclerosis: New Insights on Induction, Escalation, Oral Agents, and Monitoring

A continuing medical education activity sponsored by NAMCP and AAMCN.

Optimizing Treatment Regimens, Switching and Sequencing in Multiple Sclerosis: Leveraging Data to Make Informed Decisions is a 3-part live webinar series that will provide attendees with
the latest information in the management of Multiple Sclerosis

This is Part 2 of the series focusing on improving quality of life and patient
adherence in the treatment of Multiple Sclerosis

This activity is an archive from the webinar held December 11, 2019

This activity is valid from January 1, 2020 to January 1, 2022

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by educational grants from
Biogen and Genzyme Corporation

Description:
Multiple Sclerosis (MS) is a chronic progressive disease. It is the most common neurological cause of disability among young adults, with a prevalence of approximately 400,000 cases throughout the US, and every week around 200 people are diagnosed with the disease. Although there is still no cure for MS, many advances in MS treatment have arrived in recent years, allowing patients to manage these symptoms and improve their quality of life. While the explosion of these therapies have shown the ability to improve outcomes and quality of life in patient's MS, it makes staying current with best practices a challenge. This webinar series will allow attendees to be aware of the current treatment landscape as well as the cost implications to best develop a benefits design strategy and treatment plans that can minimize the economic burden and optimize care.

Upon completion of this activity, participants will be able to:

  • Assess challenges to patient adherence, dosing and quality of life in MS management

  • Discuss the evolving role on oral agents in the treatment of multiple sclerosis (MS) and their effect on patient adherence

  • Apply the latest updates on the use of MRI and clinical findings that may prompt consideration of switching therapy for MS

  • Examine strategies to monitor and manage adverse events associated with current and emerging disease modifying therapies in MS in order to improve patient adherence and quality of life

  • Analyze care pathways and their application to manage and improve economic outcomes in MS
     

Faculty: Lily Jung Henson, MD, MMM, FAAN, FACHE
Medical Director, General Neurology
Swedish Neuroscience Institute
Clinical Associate Professor of Neurology
University of Washington

Disclosure:

Lily Jung Henson, MD has no relevant financial relationships to disclose. Her presentation has been reviewed for any bias.
 
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by educational grants from
Biogen and Genzyme Corporation

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue